U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1) يوليو 28, 2021 System Admin الرعاية الصحية
Three steps to keep health and benefits plan costs in Bahrain under control يوليو 28, 2021 System Admin الرعاية الصحية
إقبال واسع وتوافد مستمرعلى مراكز التحصين للحصول على لقاح كوفيد 19 يوليو 28, 2021 System Admin الرعاية الصحية
Jordan National Rehabilitation Strategic Plan 2020-2024 launched يوليو 28, 2021 System Admin الرعاية الصحية
ESDF follows up on planned pharmaceutical production in Libya through its investment in Bosnia’s Bosnalijek يوليو 28, 2021 System Admin الرعاية الصحية
Two-week partial curfew confirmed, LD 500 million allocated to fight Coronavirus يوليو 28, 2021 System Admin الرعاية الصحية
Spar to provide 10 000 frontline healthcare workers with vouchers يوليو 28, 2021 System Admin الرعاية الصحية
After COVID, Saudi Arabia set to turn its attention to an older scourge: viral hepatitis يوليو 28, 2021 System Admin الرعاية الصحية
Calls for increased early detection of heart conditions among young in Gaza يوليو 28, 2021 System Admin الرعاية الصحية
